Pyk2 has been shown to control p53 levels, cell cycle progression, and proliferation in ovarian carcinoma cells that express both FAK and Pyk2, and in FAK−/− mouse embryo fibroblasts that undergo upregulation of Pyk2 due to loss of FAK [37]. Here, PTK2 is linked to ovarian carcinoma.